Streetbeat News

Products Services

TGLS

Tecnoglass has announced its entry into the vinyl window market, which is expected to more than double its addressable market. The new product will be under the ES Windows Legacy brand, with deliveries expected to start in November 2023.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2023 | 11:18 am

AAPL

INTC

Apple Inc.'s 13-inch MacBook Air, powered by Intel Corporation's Core processor, is now available at a discount of $560 on Woot, bringing the price down to less than $1,000. This is one of the best prices recently for MacBooks powered by Intel processors.

Portfolio Pulse from Rounak Jain

August 28, 2023 | 11:13 am

AKRO

Akero Therapeutics has collected all samples and data required for a readout of topline results from its Phase 2b SYMMETRY study of Efruxifermin in NASH. The company expects to release the readout in October this year.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2023 | 11:13 am

GANX

Gain Therapeutics has announced preclinical data showing that its lead drug candidate GT-02287 significantly decreased Parkinson's disease-associated pathology and improved motor dysfunction in two different preclinical models of Parkinson's disease. The drug also significantly reduced plasma Neurofilament Light Chain levels, a biomarker for neurodegeneration, in a mouse model of GBA1-PD. The findings will be presented at the International Congress of Parkinson's Disease and Movement Disorders in Copenhagen, Denmark.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2023 | 11:11 am

PRAX

Praxis Precision will present patient-focused endpoints from its Essential1 study of Ulixacaltamide (PRAX-944) in Essential Tremor at the International Parkinson & Movement Disorder Society's International Congress of Parkinson's Disease & Movement Disorders.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2023 | 11:09 am

NVCR

Novocure's Phase 3 trial of Tumor Treating Fields (TTFields) in combination with paclitaxel for platinum-resistant ovarian cancer did not meet its primary endpoint of overall survival. Patients receiving TTFields therapy plus paclitaxel showed a median overall survival of 12.2 months, compared to 11.9 months for those treated with paclitaxel alone. The therapy was well-tolerated with no added systemic toxicities.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2023 | 11:06 am

VSTM

Verastem Oncology has partnered with Genfleet Therapeutics for three oncology discovery programs. The deal is worth $11.5M for the first program, with a potential total deal size of up to $625.5M excluding royalties if Verastem exercises its option. Verastem Oncology will have exclusive rights to obtain a license to each of the compounds after successful completion of pre-determined milestones in Phase 1 trials.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2023 | 11:05 am

OFIX

Orthofix Medical has announced the full commercial launch and completion of the first cases in the U.S. with the 7D FLASH Navigation System Percutaneous Module 2.0. This new system provides new planning features and increased functionality.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2023 | 11:02 am

PERF

Perfect Corp. has partnered with ELEMIS to launch the global British skincare brand. The ELEMIS AI Skin Experience will provide customers with a detailed skin assessment and match them with the best skincare product regimen.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2023 | 10:54 am

ANIP

ANI Pharmaceuticals has received FDA approval for the Abbreviated New Drug Application for Estradiol Gel, 0.1%, a generic version of Divigel. This drug is used for severe vasomotor symptoms (hot flashes, night sweats) due to menopause.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2023 | 10:52 am